Castle Biosciences, Inc. (CSTL)

32.32 +0.01 (+0.03%) USD  |  NASDAQ  |  Sep 10, 16:00
32.35 +0.03 (+0.09%) Pre-Market: 20:00
More

Castle Biosciences Cash from Operations (Annual) : 64.35M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for CSTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2017. Start Trial.
Date Value
December 31, 2025 64.35M
December 31, 2024 71.55M
December 31, 2023 -0.135M
December 31, 2022 -40.29M
December 31, 2021 -18.98M
Date Value
December 31, 2020 9.865M
December 31, 2019 7.015M
December 31, 2018 -12.29M
December 31, 2017 -12.23M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
RadNet, Inc. 298.82M
Lumexa Imaging Holdings, Inc. 17.07M
Labcorp Holdings, Inc. 1.640B
Quest Diagnostics, Inc. 1.886B
OPKO Health, Inc. -178.54M